Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
What you need to know about credit card rewards and taxes can save you money. Equip yourself with essential tips for smart financial management.
28,655 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Alphabet raising $84.75 billion marks a bold turn in how tech giants fund AI bets. This article breaks down what it c...
Oil sits below $76. bitcoin still baffles many investors as cryptocurrency momentum and macro trends diverge. This gu...
Institutional moves can reveal where smart money is flowing. Learn why highmark wealth management buys Axogen stock, ...
A high-profile Ethereum MEV bot suffered a dramatic $7.5 million loss, prompting talk of legal action. This article u...
Walmart and Costco sit at opposite ends of the retail revenue spectrum, yet their growth stories diverge in meaningfu...
Meta signals a bold move into AI compute power and model access. The shift could redefine cloud dynamics, affect riva...
The FMC stock story has been rough, but a measured, scenario-driven approach can illuminate where the year ahead migh...
Redwire posted a strong revenue beat but a bigger-than-expected loss, triggering a mid-day rally in its stock. This a...
A major fund trims a big stake in a tech name, sparking questions about risk, sector exposure, and portfolio resilien...
Retirees rely on COLA to keep up with rising prices. This piece explains why social security's 2027 cola might be lar...
As markets digest a high-stakes political address and evolving risk appetite, bitcoin nudges higher. Traders balance ...